This inventor holds 2 USPTO granted patents. Top assignees: Symbicom Ab, Symbicom Aktiebolag. Active years: 1989-1990.
Company Filing History:
Years Active: 1989-1990
Title: Erling Norrby: Innovator in Antiviral Agents
Introduction
Erling Norrby is a notable inventor based in Lidingo, Sweden. He has made significant contributions to the field of antiviral agents, holding a total of 2 patents. His work focuses on understanding and combating viral infections through innovative approaches.
Latest Patents
Norrby's latest patents revolve around the discovery of a second-step virus binding receptor found in nature on the surface of animal and plant cells. This receptor is essential for virus penetration into target cells. His research indicates that this second-step receptor can bind a wide variety of viruses from different families. The implications of his findings suggest that natural or synthetic substances analogous to the binding epitope of this receptor can be utilized for the diagnosis, prophylaxis, or treatment of viral infections.
Career Highlights
Throughout his career, Erling Norrby has worked with various companies, including Symbicom AB and Symbicom Aktiebolag. His innovative research has positioned him as a key figure in the development of antiviral therapies.
Collaborations
Norrby has collaborated with notable individuals in his field, including Karl-Anders Karlsson and Goran Wadell. These partnerships have contributed to the advancement of his research and the impact of his inventions.
Conclusion
Erling Norrby is a distinguished inventor whose work in antiviral agents has the potential to significantly influence the treatment of viral infections. His discoveries and collaborations highlight the importance of innovation in the fight against viruses.